等待開盤 11-26 09:30:00 美东时间
+0.550
+0.91%
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
今天 10:07
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Mizuho analyst Vikram Malhorta maintains Equity Residential (NYSE:EQR) with a Neutral and lowers the price target from $66 to $65.
11-24 22:20
Land & Buildings Investment Management exited VICI Properties (VICI) and American Tower (AMT) during the third quarter, according to its latest 13F filing. Land & Buildings is known as an investment f...
11-20 02:47
今日重点评级关注:HC Wainwright & Co.:维持Oncolytics Biotech"买入"评级,目标价从5美元升至10美元;HC Wainwright & Co.:维持Barinthus Biotherapeutics"买入"评级,目标价从3美元升至4美元
11-18 15:28
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Wells Fargo analyst James Feldman maintains Equity Residential (NYSE:EQR) with a Equal-Weight and lowers the price target from $68 to $62.
11-10 22:36
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
11-05 10:35
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31